Chinese hamster ovary (CHO) cells comprise a variety of lineages including CHO-DXB11, CHO-K1, CHO-DG44 and CHO-S. Despite all CHO cell lines sharing a common ancestor, extensive mutagenesis and clonal selection has resulted in substantial genetic heterogeneity among them. Data from sequencing shows that different genes are missing in individual CHO cell lines and each cell line harbors a unique set of mutations with relevance to the bioprocess.
Introduction
CHO cells comprise a variety of lineages such as CHO-DXB11 (or DUKX), CHO-K1, CHO-DG44 and CHO-S that share a common ancestor. The original CHO cell line was generated by Dr. Theodore Puck in 1956 who isolated spontaneously immortalized fibroblasts from a culture of ovarian cells of a Chinese hamster [1] . CHO-K1 was derived from a subclone of the original cell line in 1957. In 1980, CHO-DXB11 (or DUKX) was generated through chemical mutagenesis of CHO-K1 [2] . The dihydrofolate reductase (dhfr) deficiency enabled the stable introduction of transgenes when co-transfected with a functional copy of the dhfr gene as a selection marker. In 1983, Urlaub et al. [3] deleted both dhfr alleles by mutagenesis of a different CHO cell starting population, thus generating CHO-DG44 lineage. In 1991, the CHO-S cell line was generated from another CHO cell starting population. Nowadays, all these cell lines are widely used for the production of biopharmaceuticals.
Since the introduction of the original CHO cell line, extensive mutagenesis and clonal selection has resulted in substantial genetic heterogeneity among the different CHO cell lineages [4] [5] [6] . Karyotyping of various CHO cells underpins this genetic diversity by highlighting several deletions, translocations or rearrangements of chromosomal segments [4] . Even within a supposedly monoclonal population of the ancestor of CHO-K1, substantial heterogeneity was found [7] . Similar observations were made in a karyogram of CHO-DG44 cells [8] . Further evidence concerning phenotypic diversity comes from substantial gene copy number variations (CNVs), ploidy and small-nucleotide polymorphisms (SNPs) among CHO-K1, CHO-DG44 and CHO-S lineages [5] . Finally, epigenetic variations (e.g. histone modifications, chromatin remodeling and DNA methylation) modifying gene expression also exists for CHO cells [9] [10] [11] .
In recent years, sequencing data demonstrated genetic differences among different CHO cell lines leading to speculation on their relevance for bioprocessing [4, 5, [12] [13] [14] . However, while sequencing data increases, studies investigating their biological/technological significance remain scarce. In this study, we examined host cell-specific differences of production clones among three widely used CHO cell lines (CHO-K1, CHO-S and CHO-DG44). We expressed the same mAb in all three CHO cell lines to avoid product-related effects on the host cell line such as the physicochemical properties of the recombinant product [15] or on nutrient requirements (e.g. amino acid usage). Position effects, which are commonly observed upon random integration of plasmid DNA, were circumvented by using BACs as genetic transfer vehicle providing a quasi-isogenic environment of the recombinant gene in different production clones. These vectors achieve position-independent, but gene copy number (GCN)-dependent, high and stable product expression even without the need of transgene amplification [16] . Cell growth and product formation were studied in batch, fed-batch and semi-continuous perfusion cultures. Two different cell culture media were used for all cell lines to investigate the effect on the bioprocess and mAb quality. Phenotypic differences among CHO cell lineages were confirmed in our study demonstrating the effect of genotypic variations and their relevance for bioprocessing. The combination of CHO sequence-specific knowledge and lineage-specific cultivation behavior will be a powerful tool for future cell line engineering and development, as well as improvement of bioprocesses and cell culture media.
7 cultivation. Routine cultures were inoculated at a cell concentration of 3×10 5 c/mL in 125 mL
Erlenmeyer shake flasks (Corning) at a working volume of 35 mL and cultivated in an ISF1-X incubator shaker (Kuhner) operated at 37°C, 140 rpm, 7% CO2 and 90% relative humidity.
The cells were split every 3 to 4 days.
Adaptation to ActiCHO TM P (GE Healthcare) was performed by direct inoculation into the alternative medium. When the cells reached similar concentrations and viabilities as in CD CHO, the homogeneity (absence of subpopulations) of the successfully adapted cell lines was confirmed by flow cytometry according to a previously published protocol [17] . The absence of any low or non-producing subpopulations was confirmed by visualization of intracellularly stained antibody heavy and light chains with FITC-conjugated anti-human γ-chain (Sigma)
and Alexa Fluor-647-conjugated anti-human λ-chain specific antiserum (Thermo Scientific),
respectively. Subsequently, research cell banks were prepared in CryoMaxx II (GE Healthcare) for all following experiments.
Bioprocessing in batch, fed-batch and perfusion mode
Batch and fed-batch experiments were performed in a shake incubator at the conditions described above. 500 mL Erlenmeyer shake flasks (Corning) were inoculated at a starting cell concentration of 3×10 5 c/mL and a working volume of 130 mL using ActiCHO P or CD CHO as basal media. Cultures were terminated once the viability dropped below 60%. All experiments were conducted as biological triplicates from the same inoculum and operated as individual cultivations.
Batch experiments were analyzed daily for cell concentration, viability, antibody and metabolite concentrations, as well as osmolality.
In fed-batch experiments, two strategies were compared using different basal and feed media. 
Cell concentration and viability
The total cell concentration was quantified using a Z2 Coulter Counter™ (Beckman Coulter) according to the manufacturer's instructions. The viability was determined by trypan blue dye exclusion with a Neubauer improved hemocytometer (MedPro).
Antibody concentration
Antibody concentrations were determined by Bio-Layer Interferometry on an Octet™ QK (Pall) as previously described [18] .
qPCR
Preparation of cDNA was previously described [19] . qPCR was performed using the MiniOpticon™ system with 48-well low white PCR plates and microseal B film sealer (all from BioRad). All primers were designed using the Primer3 web application [20] and synthesized (Sigma-Aldrich). Primers were designed to amplify fragments of the nt-sequence in the constant regions of the mAbs heavy and light chain as shown in Tab.1. The genes of β-actin (ACTB) and the eukaryotic translation initiation factor 3 subunit I (EIF3I) served as internal reference genes. qPCR was performed with 3 ng of cDNA including non-template controls, negative controls and no-reverse-transcriptase controls. Next to the template, each reaction mix contained 10 µL KAPA PROBE Fast Universal (peqlab) and 6 pmol of each primer. qPCR was performed in 2-step mode and all samples were measured in triplicates of three biological samples in two technical runs. Data evaluation and calculations based on the 2−ΔΔCq method [21] were previously described [19, 22] . Data normalization was performed using both reference genes.
Antibody purification
For analysis of antibody product quality, cell culture supernatants were purified using HiTrap™ MabSelect SuRe™ 1 mL columns according to the manufacturer's recommendations (GE Healthcare).
Glycan analysis
Glycoprofiling was performed to investigate oligosaccharide distribution of antibody product upon harvest from fed-batch cultures. The cell suspension was centrifuged at 170×g, the supernatant clarified using a 0.22 µm filter (Express PLUS, Merck Millipore) and diluted with PBS to a concentration of 1 to 2 mg/mL. N-glycan profiles of the Fc regions of the monoclonal antibodies were determined by IdeS proteolytic digestion and electrospray mass spectrometry according to a published protocol [23] . This procedure was modified by including carboxypeptidase B to remove unprocessed C-terminal lysine residues to improve the quality of the data obtained for the Fc region of the heavy chain. Also, a reduction step was introduced to improve the quality of data obtained for the light chain and the heavy chain Fab region. Analysis was performed using the separation offered by reversed phase liquid chromatography in combination with detection by electrospray Q-Tof mass spectrometry. Fc fragment signals having masses corresponding to N glycan isoforms G0, G0F, G0F-Gn, G1F-Gn, G1F, G2F, G1F+SA1, G2F+SA1, G2F+SA2, Man5 to Man9, Man9+Glc, and Man9+2Glc were investigated and their relative abundance estimated from the intensity of these signals. The small signals for N glycan isoforms G1 and G2 were not amenable to quantification as their mass is only separated by 6 Da from the sodium adducts of G0F and G1F isoforms.
Differential Scanning Calorimetry
Thermal denaturation of antibody samples was analyzed using automated differential scanning calorimetry (DSC). All DSC measurements were performed on a VP-DSC MicroCal LLC equipment (GE Healthcare). Protein solutions were sampled from 96-well plates using the robotic attachment. Protein concentration of all samples was 10 μM. The temperature profile was recorded between 20°C and 100°C with a scan rate of 1°C/min. The results were evaluated and fitted with Origin 7.0 software (OriginLab). The unfolding states of the antibodies were fit using the non-two state unfolding model in the software.
Results

Generation of recombinant CHO cell lines and media adaptation
Unlike randomly integrated plasmid DNA, which often results in transfectants with substantially differing rates of recombinant protein expression, BAC based vectors enable a more comparable and stable product expression even without the need of transgene amplification. For this study, three recombinant CHO cell lines were generated by transfection with the same BAC constructs in CHO-K1, CHO-S and CHO-DG44 host cell lines. Among all screened mini-pools, the average specific mAb production rates prior to subcloning were 5.04 ± 2.37 (CHO-K1), 3.29 ± 1.82 (CHO-S) and 1.10 ± 0.73 (CHO-DG44)
picogram mAb per cell and day (pcd).
Cell line development and clone selection was initially performed in CD CHO. To investigate potential medium-specific effects, all three CHO cell lines were adapted to a second chemically defined cell culture medium (ActiCHO P). Direct adaptation was successful and all three recombinant CHO cell lines reached similar or even higher cell concentrations and viabilities during routine cultivation as in the initial medium (Supplement 1). Furthermore, a successful medium adaptation was confirmed by affirming the homogeneity of all adapted cell lines and the absence of any low or non-producing subpopulations (Supplement 2).
Batch evaluation of CHO-K1, CHO-S and CHO-DG44 cell lines
Batch cultivation revealed higher peak cell concentrations for CHO-S and CHO-DG44 than for CHO-K1 ( Fig.1 ; Supplement 3). CHO-S cells grew with the highest cell-specific growth rate (Tab.2), reached the maximum cell concentration first and had the shortest process duration (Fig.1 ). Higher cell concentrations were obtained using ActiCHO P. CHO-K1 showed 4 to 6-fold increased cell-specific mAb production rates compared with CHO-S and CHO-DG44 during batch culture. Consequently, these cell cultures reached the highest product titers and CHO-S the lowest titers in both media. The diagram plotting the VCCD against mAb titer (Fig. 1 ) demonstrated CHO cell-specific preferences for fast growth (CHO-S) or recombinant protein production (CHO-K1). In batch culture, no major difference in titer was observed for the two cell culture media tested. The difference between the cell lines was more pronounced than the difference resulting from cultivation media.
Fed-batch evaluation of CHO-K1, CHO-S and CHO-DG44 cell lines
In fed-batch cultivation, CHO-S cells also grew with the highest cell-specific growth rates during the initial five days (Tab.2; Supplement 3). The final mAb titer was generally higher in ActiCHO P with CHO-DG44 reaching 670 mg/L followed by CHO-K1 (460 mg/L) and CHO-S (370 mg/L). In CD CHO fed-batches, CHO-K1 cells (350 mg/L) produced higher titers than CHO-S (175 mg/L) and interestingly the lowest mAb concentration was determined in cultures of CHO-DG44 (115 mg/L) because of poor biomass accumulation and low mAb production rates (Fig.1, Tab. 2). These results demonstrated that the addition of feed concentrates substantially influenced cell accumulation by favoring one CHO host over the other regarding their specific nutrient demands. Nevertheless, cell-specific mAb production rates remained highest in CHO-K1 followed by CHO-DG44 and CHO-S (Tab.2.). This was also observable from Fig.1 showing CHO cell-specific preferences for either biomass synthesis (CHO-S) or recombinant protein production (CHO-K1).
Compared to batch cultivation, feed supplementation of CHO-K1 cells in ActiCHO P resulted in doubling peak cell concentrations but only 10-20% higher titers due to a significant reduction of cell-specific mAb production rates. Feed supplementation of CHO-S cells did not significantly impact peak cell concentrations. However, due to a substantially prolonged process duration by six days, VCCD increased significantly and boosted mAb titers by more than six-fold. In CD CHO, feed supplementation of CHO-S cells was less effective in increasing VCCD and process duration than in ActiCHO P. Thus, final titers improved only 2.5-fold compared to batch cultivation. Fed-batch cultivation of CHO-DG44 cells doubled peak cell concentrations, VCCD and cell-specific production rates compared to batch cultures.
This improved mAb titer more than five-fold. Interestingly, feed supplementation in CD CHO did not improve the process performance compared to batch cultivation.
Perfusion evaluation of CHO-K1, CHO-S and CHO-DG44 cell lines
To study the CHO cell lines under quasi steady-state conditions we used a lab-scale semicontinuous perfusion system with daily media exchange ( Fig.1; Supplement 3 ). CHO-S cells grew with the highest cell-specific growth rate (Tab.2) and cell concentration in theses cultures peaked first (Fig.1) . 
Evaluation of mRNA
To investigate if high cell-specific mAb production rates coincided with high heavy and light chain mRNA levels, we analyzed both parameters on several days during fed-batch cultivation. For all three CHO cell lines, cell-specific mAb production rates declined continuously, while HC and LC mRNA accumulated with increasing variability between biological triplicates (Figure 2 ). Therefore, we statistically evaluated product-specific mRNA and qP on day 4 when all clones had comparable cell densities and cultures were still in the exponential growth phase. Interestingly, HC and LC mRNA in CHO-K1 cells were significantly influenced by the feed medium and this was reflected in the specific productivity (Supplement 4). Statistical evaluation gave also evidence that HC mRNA contributed more directly to a higher qP than LC mRNA.
CHO host cell line and mAb product quality
The observed phenotypic differences during cultivation of the different CHO cell lines prompted us to analyze the secreted product. We decided to investigate mAb product from fed-batch cultivation harvest only, first, because most currently executed bioprocesses rely on this strategy and second, we speculated that due to product accumulation in fed-batch even minor cell line-specific product-related differences might become more visible compared to other process modes.
In general, all three CHO cells expressed mainly core fucosylated complex biantennary Fc glycans with predominantly G0F, G1F and G2F glycoforms (Fig.3) , similar to naturally occurring human serum IgG [24] . The relative abundance of some glycoforms was influenced by CHO cell line or media. For example, when the media was changed from ActiCHO P to CD CHO, the amount of galactosylated mAb increased from 17% to 37% for CHO-K1 and CHO-S, but remained constant for CHO-DG44. The abundance of agalactosylated glycoforms (G0F) was higher for CHO-S than for CHO-K1 and CHO-DG44 expressed mAb. Product mannosylation, fucosylation and aglycosylation were less influenced by the media, but merely an inherent trait of the CHO cell line. CHO-S cells expressed the lowest amount of mannosylated product (2-3%) relative to CHO-K1 (5-9%) and CHO-DG44 cultures (11-13%). Product fucosylation was highest in CHO-S (94-96%) followed by CHO-K1 (82-84%) and CHO-DG44 (71-83%). The amount of aglycosylated mAb was low in CHO-K1 (2-5%) and CHO-S (1%) and no aglycosylated mAb was detected in CHO-DG44 cultures.
In addition to the Fc glycosylation site, the herein expressed mAb contained a further glycan moiety in the light chain region. This glycosylation site also contained mainly core fucosylated complex biantennary glycans with predominantly G0F, G1F and G2F glycoforms, but occasionally one or two sialic acid residues (Fig.4) . CHO-S cells expressed the lowest amount of mannosylated product (≤ 1.5%) relative to CHO-K1 (4-6%) and CHO-DG44
cultures (5-13%). Product fucosylation of the light chain was lowest in CHO-S (~46%)
followed by CHO-DG44 (76-88%) and CHO-K1 (83-90%). The amount of sialylated mAb was highest in CHO-K1 (21-36%) followed by CHO-DG44 (15-19%) and CHO-S cultures (6-15%). Despite detectable changes of mAb glycosylation they were subtle and their pharmacological relevance would need to be evaluated in more detail.
Mammalian cells commonly perform post-translational modifications during protein production that are essential for protein folding, stability and function [25, 26] . To investigate conformational stabilities of the same mAb produced by different CHO hosts we analyzed thermal stabilities of the protein. DSC measurements revealed four unfolding transitions for the investigated mAbs (Fig.5 ). Most important, the media used for cultivation did not influence the thermal stability of expressed mAb. Remarkably, the first mAb unfolding transition (Tm1) started 1.7 °C earlier when expressed by CHO-S (64.3 °C ± 0.2) compared to mAb expressed in CHO-K1 or CHO-DG44 (both 66.0 °C ± 0.3). To further investigate potential reasons for the differences of thermal stability we analyzed the amino acid sequence of mAb product by mass spectrometry (data not shown) and found that the mAb expressed in CHO-S (but not CHO-K1 and CHO-DG44) missed the C-terminal serine in the light chain.
Discussion
To date, more than 70% of all recombinant biopharmaceuticals are expressed in CHO cells [27] . However, current literature is scarce in CHO host comparisons, suggesting that such knowledge can be an advantage. It is not surprising that companies rely on individually selected host cell line(s) to ensure repeatedly reaching the desired product quantity and quality attributes of any to-be-expressed biomolecule. To shed more light on this topic, we investigated growth and recombinant mAb expression of three commonly used CHO cell lines in different cultivation modes. The herein presented study demonstrated host-specific physiologic preferences favoring either biomass synthesis or antibody production (Fig.1) .
CHO host favors mAb production or biomass synthesis
For a proper comparison of cell lines that were indeed representative for the respective CHO host, we have applied the same transfection and selection criteria for all three monoclonal cell lines. Only the best producers with adequate growth properties were selected according to good practice in cell line generation.
Already during cell line generation and screening of polyclonal mini-pools, CHO-K1 cells revealed a higher mean qP than CHO-S and CHO-DG44. This observation was persistent from the initial mini-pools until the finally derived monoclonal cell lines. Combined with the consistent genetic environment provided by the BAC constructs, we firmly believe that the reported results are due to phenotypic differences rather than clonal variations.
Cell culture media are complex nutrient solutions that contain up to 100 different components at varying concentrations. This makes medium adaptation complex and may affect cell growth, viability, protein expression and even genomic stability [18, 28, 29] . In our case, direct adaptation was successful for all three CHO cell lines without introducing any lag phases or lowering the viability (Supplement 1). Despite genetic changes were not investigated, the absence of low or non-producing subpopulations was confirmed upon medium adaptation (Supplement 2).
Cell growth and peak cell concentrations were generally higher in ActiCHO P (Tab.2) during all process strategies (i.e. batch, fed-batch and semi-continuous perfusion cultures) indicating that a balanced media formulation can influence the performance of the cultivated cell lines [18] . Independent of medium or process type, CHO-S cells grew with 10-50% higher cellspecific growth rates than CHO-K1 and CHO-DG44 cells (Tab.2). This highlighted CHO host-inherent traits towards individual preferences for cell growth. Interestingly, also the nontransfected CHO-S host cell line reached higher growth rates than CHO-K1 and CHO-DG44 during batch and routine cultivation.
CHO-K1 cells had the highest cell-specific productivities as indicated by high mAb titers with relatively low biomass accumulation. CHO-S showed opposite characteristics (Tab.2, Fig.1 ).
CHO-DG44 ranked in-between the two other CHO cell lines. Remarkably, this trend was consistent in all cultivation modes and cell culture media. Determination of GCN showed between 1-2 LC copies and 2-4 HC copies in the different CHO cell lines despite both cDNAs were part of the same BAC. This was most likely a result of the underlying logarithmic calculation. In our dataset, we found no statistically significant correlation of product-related mRNA to cell-specific mAb production rates over the whole process since both parameters changed with process time for all three CHO cell lines (Figure 2 ). Considering the extensive mutagenesis and clonal selection of the derived CHO host cell lines [4] , we assume that the determined expression differences related to the cellular phenotype and metabolism rather than differences in product-specific GCN (or mRNA), location of the transgenes [12] , or type of cell cultivation. The influence of GCN and amount of transcript on protein expression levels is addressed since a long time by several publications and remains controversial [30] [31] [32] [33] [34] .
Differing rates of product synthesis among the CHO host cell lines could be due to unequal capacities and processing efficiencies of their translational machineries. For example, a larger ER and higher mitochondrial mass of CHO-K1 has recently been associated with a higher qP compared to CHO-DUXB11 [35] . The ER is important for proper folding and assembly of secreted proteins. If the amount of irreversibly misfolded proteins in the ER exceeds a certain limit, cells will trigger the unfolded protein response and eventually apoptosis [36, 37] . A larger ER thus favors higher secretion rates but also the survival of high-producing cells and the processing of difficult-to-fold proteins. Mitochondria provide the energy to many cellular processes including protein folding [38] . A higher mitochondria mass may be advantageous to cells in order to self-fuel their required energy to cope with the resulting stress of misfolded proteins in the ER. Since both ER and mitochondria occupy a large proportion of the total cellular volume, capacities for recombinant protein expression may be reflected by cell size.
Interestingly, we observed a larger cell size for high producing CHO-K1 cells (15.7 µm ±0.7)
compared to low producing CHO-DG44 (14.2 µm ±0.5) and CHO-S cells (13.7 µm ±1.1) during semi-continuous perfusion cultivation.
CHO host influences mAb glycosylation profile
The glycosylation profile considerably determines mAb safety and efficacy [39] . Changes in Fc glycosylation can alter Fc conformation, receptor binding and immune effector functions as reviewed in detail elsewhere [40] .
Our study showed that mAb glycosylation was influenced by the applied CHO expression host ( Fig.3 and 4) . Mannosylation was higher and fucosylation was lower when mAb was expressed by CHO-DG44 followed by CHO-K1 and CHO-S. Antibodies with high-mannose and low-fucose content generally increase ADCC [41, 42] . Galactosylation, which increases IgG effector functions [43] , was merely influenced by the applied cultivation media. Media constituents that affect mAb galactosylation include uridine, manganese chloride and galactose [44, 45] . However, their concentrations in the applied cell culture media were not quantified. In general, CHO-K1 revealed a higher degree of mAb galactosylation than CHO-DG44 followed by CHO-S. Only carbohydrates of the LC (but not Fc part) contained sialic acid residues indicating that sialylation was more a consequence of steric accessibility.
Sialylation is often associated with improved serum half-life [46] or anti-inflammatory activity [47] . Sialylation of mAb was higher for CHO-K1, followed by CHO-DG44 and then CHO-S cells. Host-specific glycosylation patterns may be related to the heterogeneity of CHO cells that harbor and express a different set of genes relevant for glyco-processing [5, 13] .
Lewis et al. [5] have shown that among 256 enzymes associated with glycosylation in
Cricetulus griseus, 13%, 2% and 25% have non-synonymous SNPs, frame-shifting indels, or
CNVs, respectively, in at least one cell line of CHO-K1, CHO-DG44 and CHO-S. While not all SNPs will have a measurable effect on enzyme activity or substrate preference, glycans are produced through long, branching pathways, which increases the probability of having a mutation that changes the final glycoform in any given cell line. This hypothesis supports our results that different CHO expression systems harbor cell type-specific glycosylation patterns, which can be exploited depending on the produced protein and its requirements in vivo.
Mammalian cells commonly perform post-translational modifications during protein production that are essential for protein folding, stability and function [25, 26] . Higher thermal stabilities improve mAb expression rates [48, 49] . In our study, the least stable mAb (CHO-S) was expressed at the lowest cell-specific rate (Tab.2). However, the thermal stability of CHO-DG44 expressed mAb was similar to CHO-K1 despite mAb expression rates were slightly better than CHO-S. It remains elusive if or to which extent the thermal stability difference of 1.7 °C (Tm1) contributed to protein expression. A potential reason for lower stability could be a missing C-terminal serine in the LC of mAb expressed in CHO-S (but not CHO-K1 and CHO-DG44) as identified by mass spectrometry. If this was due to mAb processing differences by the CHO host currently remains undetermined. Shen et al. [50] showed that deletion of the C-terminal serine of the λ LC improved thermal and high pH stabilities, transient expression, purification yield and ADCC function of an IgG1 without affecting antigen binding. The herein investigated mAb also was an IgG1 λ, but the thermal stability was higher when the C-terminal serine was present (Fig.5) . The cultivation media did not influence mAb stability.
Conclusion
In recent years, high-throughput technologies have created an ever-increasing amount of sequencing data that demonstrates the genetic heterogeneity of CHO cell lines. However, the influence of these genetic differences on the phenotype of different CHO cell lines and finally the effect on bioprocessing has not yet been investigated in detail. In this study, we found that the cellular phenotype determines CHO cell line-specific preferences for mAb production or biomass synthesis. CHO-K1 metabolism favored mAb expression, whereas CHO-S metabolism had a preference for biomass formation and CHO-DG44 ranked in-between the two. These preferences were independent of process type (i.e. batch, fed-batch, or perfusion) and cell culture media. Therefore, the choice of the CHO host cell line had a fundamental impact on the production process. Currently, genomic and phenotypic variations of CHO cells are not well understood and often not taken into consideration when selecting a host cell line.
Genetic differences between host cell lines should be examined in biological experiments to better understand their impact on the cellular phenotype and bioprocess. The combination of CHO sequence-specific knowledge and lineage-specific cultivation behavior will be a powerful tool for future cell line engineering approaches and cell line development, as well as improvement of bioprocesses and cell culture media. The results of this study demonstrate that the genetic background substantially influences the phenotypic properties of the host cell also affecting productivity and glycosylation. Therefore, the choice of the host cell line is of key importance to achieve the desired process characteristics and product quality.
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